These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8211443)

  • 1. Preventing malaria.
    Fleming AF
    S Afr Med J; 1993 May; 83(5):368-9; author reply 370. PubMed ID: 8211443
    [No Abstract]   [Full Text] [Related]  

  • 2. Atovaquone and proguanil hydrochloride for prophylaxis of malaria.
    Shanks GD; Kremsner PG; Sukwa TY; van der Berg JD; Shapiro TA; Scott TR; Chulay JD;
    J Travel Med; 1999 May; 6 Suppl 1():S21-7. PubMed ID: 23573549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atovaquone and proguanil hydrochloride for treatment of malaria.
    Kremsner PG; Looareesuwan S; Chulay JD
    J Travel Med; 1999 May; 6 Suppl 1():S18-20. PubMed ID: 23573548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proguanil combined with dapsone chemoprophylaxis for malaria.
    Yeo AE; Edstein MD; Shanks GD
    Med J Aust; 1992 Jun; 156(12):883. PubMed ID: 1603019
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of atovaquone-proguanil in treating imported malaria in Japan: the second report from the research group.
    Kimura M; Koga M; Kikuchi T; Miura T; Maruyama H
    Parasitol Int; 2012 Sep; 61(3):466-9. PubMed ID: 22484597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proguanil for malaria prophylaxis.
    Rombo L; Hedman P; Kihamia CM; Ramji BD; Björkman A; Bengtsson E
    Lancet; 1983 Apr; 1(8331):997. PubMed ID: 6132308
    [No Abstract]   [Full Text] [Related]  

  • 7. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
    Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL;
    Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports.
    Färnert A; Lindberg J; Gil P; Swedberg G; Berqvist Y; Thapar MM; Lindegårdh N; Berezcky S; Björkman A
    BMJ; 2003 Mar; 326(7390):628-9. PubMed ID: 12649236
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of malaria in pregnancy.
    Markus MB
    S Afr Med J; 1985 Jun; 67(24):960. PubMed ID: 4002084
    [No Abstract]   [Full Text] [Related]  

  • 10. Subacute clinical forms of Plasmodium falciparum malaria in travelers receiving chloroquine-proguanil prophylaxis.
    Klement E; Chauveheid MP; Thellier M; Bricaire F; Danis M; Caumes E
    Clin Infect Dis; 2001 Jul; 33(1):e1-2. PubMed ID: 11389510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of imported malaria at the academic medical center, Amsterdam, the Netherlands.
    Baas MC; Wetsteyn JC; van Gool T
    J Travel Med; 2006; 13(1):2-7. PubMed ID: 16412103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass proguanil prophylaxis.
    Saarinen M; Thoren E; Iyambo N; Carlstedt A; Shinyafa L; Fernanda M; Paajanen H; Paajanen K; Indongo I; Rombo L
    Lancet; 1987 Apr; 1(8539):985-6. PubMed ID: 2882383
    [No Abstract]   [Full Text] [Related]  

  • 13. New options for the prevention and treatment of malaria: focus on the role of atovaquone and proguanil hydrochloride.
    Shanks GD
    J Travel Med; 1999 May; 6 Suppl 1():S1. PubMed ID: 23573544
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model.
    Deye GA; Miller RS; Miller L; Salas CJ; Tosh D; Macareo L; Smith BL; Fracisco S; Clemens EG; Murphy J; Sousa JC; Dumler JS; Magill AJ
    Clin Infect Dis; 2012 Jan; 54(2):232-9. PubMed ID: 22052893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Post-malaria neurological syndrome complicating a relapse of Plasmodium falciparum malaria after atovaquone-proguanil treatment].
    Forestier E; Labe A; Raffenot D; Lecomte C; Rogeaux O
    Med Mal Infect; 2011 Jan; 41(1):41-3. PubMed ID: 20800398
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris].
    Blondé R; Naudin J; Bigirimana Z; Holvoet L; Fenneteau O; Vitoux C; Bourdon O; Angoulvant F; Lorrot M; D'Ortenzio E; Bourrillon A; Le Bras J; Matheron S; Faye A
    Arch Pediatr; 2008 Mar; 15(3):245-52. PubMed ID: 18321692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malaria--a shadow over Africa.
    Miller LH; Greenwood B
    Science; 2002 Oct; 298(5591):121-2. PubMed ID: 12364787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythema multiforme and Malarone(®).
    Becher G; Wylie G
    Travel Med Infect Dis; 2012 Sep; 10(5-6):279-80. PubMed ID: 22951669
    [No Abstract]   [Full Text] [Related]  

  • 19. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America.
    Legrand E; Demar M; Volney B; Ekala MT; Quinternet M; Bouchier C; Fandeur T; Rogier C; Carme B; Puijalon OM; Esterre P
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2280-1. PubMed ID: 17438062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.